BPC 157 Peptide Injection upregulates the expression of vascular endothelial growth factor (VEGF), stimulates the proliferation and migration of endothelial cells, and promotes the formation of new blood vessels. This process is crucial for tissue repair, as new blood vessels can provide more oxygen and nutrients to the damaged area, accelerating healing. For example, after muscle strain or ligament tear, BPC-157 can significantly increase local blood flow, promote collagen fiber arrangement and remodeling, thereby accelerating recovery speed. BPC-157 can regulate inflammatory response, reduce the release of pro-inflammatory cytokines (such as TNF - α, IL-6), and stimulate the expression of anti-inflammatory cytokines (such as IL-10). This bidirectional regulatory effect makes it outstanding in various inflammatory diseases. For example, in arthritis models, BPC-157 can alleviate joint swelling and pain, and improve joint function. In addition, it can inhibit oxidative stress response and protect cells from free radical damage.
We not only provide pure powder and capsules, but also other dosage forms. If necessary, please contact our sales team.
Our products
|
|
|
|
|
|
|



BPC 157 COA
![]() |
||
| Certificate of Analysis | ||
| Compound name | BPC 157 | |
| Grade | Pharmaceutical grade | |
| CAS No. | 137525-51-0 | |
| Quantity | 15g | |
| Packaging standard | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 202501090025 | |
| MFG | Jan 9th 2025 | |
| EXP | Jan 8th 2028 | |
| Structure | ![]() |
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.38% |
| Loss on drying | ≤1.0% | 0.26% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.90% |
| Single impurity | <0.8% | 0.39% |
| Total microbial count | ≤750cfu/g | 80 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 400ppm |
| Storage | Store in a sealed, dark, and dry place below -20°C | |
|
|
||
|
|
||
| Chemical Formula: | C62H98N16O22 |
| Exact Mass: | 1418.70 |
| Molecular Weight: | 1419.56 |
| m/z: | 1418.70 (100.0%), 1419.71 (67.1%), 1420.71 (22.1%), 1419.70 (5.9%), 1420.71 (4.5%), 1421.71 (4.0%), 1420.70 (3.7%), 1421.71 (3.0%), 1421.71 (1.3%), 1419.71 (1.1%), 1422.72 (1.0%) |
| Elemental Analysis: | C, 52.46; H, 6.96; N, 15.79; O, 24.79 |

BPC-157 (Body Protection Compound 157) is a synthetic peptide consisting of 15 amino acids, with the amino acid sequence of Gly Glu Pro Pro Pro Gly Lys Ala Asp Ala Gly Leu Val. This polypeptide fragment was initially discovered in the degradation products of natural protective proteins (BPC) in human gastric juice. BPC 157 Peptide Injection has excellent chemical stability and can resist the degradation of digestive enzymes such as pepsin. Even in harsh environments such as digestion or enzyme reactions, it can still maintain its biological activity. This characteristic provides a theoretical basis for its oral administration, and also means that when injected, BPC-157 can stably function in the body and is not easily decomposed and ineffective.
The mechanism of action of BPC 157
Promote angiogenesis
BPC 157 can significantly promote the formation of new blood vessels, which is crucial for tissue repair. New blood vessels can bring more oxygen, nutrients, and repair cells to damaged tissues, while also carrying away metabolic waste, greatly accelerating the healing process. BPC-157 upregulates the expression of key growth factors such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), stimulating the proliferation and migration of endothelial cells and promoting the generation of new blood vessels. For example, after muscle strain or ligament tear, BPC 157 can increase local blood flow, provide sufficient nutritional support to the damaged area, promote the arrangement and remodeling of collagen fibers, and accelerate recovery speed.

Anti-inflammatory effect
BPC 157 has strong anti-inflammatory properties and can regulate the expression of various inflammatory factors, reducing acute and chronic inflammatory responses. It can reduce the release of pro-inflammatory cytokines such as TNF - α and IL-6, while stimulating the expression of anti-inflammatory cytokines such as IL-10, creating a favorable environment for tissue repair. In the inflammatory bowel disease model, BPC-157 can significantly alleviate intestinal inflammation and improve symptoms such as diarrhea and abdominal pain. In addition, it can inhibit oxidative stress response, protect cells from free radical damage, and further alleviate the damage of inflammation to tissues.

Cell protection and repair
BPC-157 promotes the repair and regeneration of damaged cells by stabilizing the cell membrane, enhancing cell migration ability. In the gastrointestinal mucosal injury model, BPC-157 can accelerate the migration and proliferation of mucosal epithelial cells, restore the integrity of the mucosal barrier, and prevent further damage to deep tissues by gastric acid and digestive enzymes. This mechanism makes it potentially applicable in the treatment of diseases such as gastric ulcers and inflammatory bowel disease. In addition, BPC-157 can reduce cell apoptosis, protect cells from adverse factors such as ischemia and toxic damage, and maintain tissue homeostasis.

Regulating growth factors
BPC-157 can stimulate the expression of various growth factors, such as IGF-1 and FGF-2, which play critical roles in cell proliferation, differentiation, and tissue repair. For example, during the process of fracture healing, BPC-157 can promote the activity of bone forming cells and the deposition of bone matrix, accelerating fracture healing. In addition, it can regulate the synthesis and degradation of extracellular matrix (ECM), providing a suitable microenvironment for tissue repair. By upregulating the expression of structural proteins such as collagen, BPC-157 can enhance the mechanical strength and elasticity of tissues, and improve functional recovery.

Activate cellular signaling pathways
BPC-157 can activate various cellular signaling pathways, such as FAK paxillin pathway, PI3K/Akt pathway, etc., which play important roles in cell migration, proliferation, and survival. For example, activation of the FAK paxillin pathway can promote the proliferation and migration of tendon cells, accelerating tendon repair; The activation of the PI3K/Akt pathway can protect cells from apoptosis and maintain tissue homeostasis. In addition, BPC-157 can regulate hippocampal gene expression, improve motor function recovery after spinal cord compression, reduce neuronal damage caused by cerebral ischemia, and demonstrate potential in neurological repair.

Clinical Application of BPC-157 Peptide Injection
Sports Medicine Injuries
Muscle strain and ligament injury
Muscle strains and ligament injuries are common sports injuries among athletes and fitness enthusiasts. BPC 157 peptide injection can accelerate the repair process of muscles and ligaments, reduce scar formation, and restore tissue elasticity and function. By promoting the orderly arrangement of collagen fibers and extracellular matrix remodeling, BPC-157 can significantly improve pain and swelling after muscle strains and ligament injuries, and shorten recovery time. A 90 day study on a complete transection model of the medial collateral ligament (MCL) in rats showed that the treatment group was significantly better than the control group in terms of functional score, biomechanical strength, and macroscopic tissue healing degree.


Tendinitis and tenosynovitis
Tendinitis and tenosynovitis are inflammatory diseases caused by repeated overuse or injury of tendons or tendon sheaths. BPC-157 peptide injection can alleviate inflammatory reactions, promote the proliferation and migration of tendon cells, and improve inflammation and pain in tendons and tendon sheaths. Many patients have reported that after using BPC-157, pain and swelling are significantly reduced, joint mobility increases, and they are able to recover to normal exercise levels more quickly.
Joint Injury
Joint injuries include arthritis, joint sprains, etc., which are common in athletes and the elderly. BPC-157 peptide injection can reduce joint inflammation, promote cartilage repair, and improve joint function. In the arthritis model, the joint swelling and pain scores of the BPC-157 treatment group were significantly lower than those of the control group, and the degree of joint cartilage damage was milder. In addition, BPC-157 can reduce joint inflammation and pain after high-intensity training, improve mobility, and is of great significance for joint protection in athletes.

Digestive system diseases

Gastric ulcer and duodenal ulcer
Gastric ulcer and duodenal ulcer are common digestive system diseases, mainly caused by damage to the gastric mucosa and duodenal mucosa by gastric acid and digestive enzymes. BPC-157 peptide injection can accelerate the repair of gastric and duodenal mucosa and reduce ulcer recurrence. By promoting the migration and proliferation of mucosal epithelial cells, BPC-157 can quickly "cover" damaged mucosa, forming a protective layer to prevent further damage from gastric acid and digestive enzymes. A study on gastric ulcer patients showed that the ulcer healing rate of the BPC-157 treatment group was significantly higher than that of the control group, and the recurrence rate was lower.
Inflammatory bowel disease
Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is a chronic inflammatory bowel disease. BPC-157 peptide injection can alleviate intestinal inflammation, promote intestinal mucosal repair, and improve intestinal function. In ulcerative colitis and Crohn's disease models, BPC-157 can reduce the release of pro-inflammatory cytokines and increase the expression of anti-inflammatory cytokines, thereby alleviating intestinal inflammation and symptoms. In addition, BPC-157 can promote intestinal anastomosis healing, reduce fistula formation, and improve intestinal wall adaptability, which is of great significance for the treatment of inflammatory bowel disease.


Intestinal fistula and anastomosis healing
Intestinal fistula and poor healing of anastomotic sites are common complications after intestinal surgery, which can lead to severe infections and malnutrition. BPC 157 peptide injection can accelerate the repair of intestinal anastomosis, reduce fistula formation, and improve intestinal wall adaptability. By promoting angiogenesis and collagen synthesis, BPC-157 can enhance the mechanical strength of the anastomotic site and prevent the occurrence of fistulas. In animal experiments, the BPC-157 treatment group showed faster healing of intestinal anastomosis and significantly reduced incidence of fistula.
Hepatopancreatic protection
BPC-157 peptide injection also has hepatopancreatic protective effects, which can alleviate alcoholic liver injury and radiation-induced liver injury, reduce oxidative stress and fibrosis. By regulating the metabolism of liver cells and the expression of antioxidant enzymes, BPC-157 can protect liver cells from damage and maintain normal liver function. In addition, BPC-157 can promote the repair and regeneration of pancreatic cells, improve pancreatic function, and has potential value for the treatment of diseases such as pancreatitis.

Neurological disorders
Spinal Cord Injury
Spinal cord injury is a serious neurological disorder that can lead to paralysis and sensory impairment. BPC-157 peptide injection can promote nerve regeneration and functional recovery after spinal cord injury. By regulating hippocampal gene expression, BPC-157 can improve motor function recovery after spinal cord compression and reduce neuronal damage caused by cerebral ischemia. In animal experiments, the motor function scores of rats with spinal cord injury in the BPC-157 treatment group were significantly higher than those in the control group, and the number of nerve fibers was more numerous and arranged in a more orderly manner.


Cerebral Ischemia
Cerebral ischemia is a neuronal damage and functional impairment caused by insufficient blood supply to the brain. BPC-157 peptide injection can reduce neuronal damage caused by cerebral ischemia and improve neurological deficits. By promoting angiogenesis and anti-inflammatory effects, BPC-157 can improve cerebral blood flow, reduce brain edema and inflammatory response, thereby protecting neurons from damage. In the cerebral ischemia model, the BPC-157 treatment group had a smaller cerebral infarction volume and faster recovery of neurological function.
Neurodegenerative diseases
Neurodegenerative diseases such as Parkinson's disease and schizophrenia are closely related to neuronal damage and death. BPC-157 peptide injection has shown potential therapeutic effects in Parkinson's disease and schizophrenia models. For example, it can alleviate central nervous system damage induced by L-NAME and improve behavioral disorders in animals. By promoting the regeneration of myelin sheaths and the repair of nerve cells, BPC-157 is expected to provide new ideas for the treatment of neurodegenerative diseases.

Frequently Asked Questions
Is peptide Sciences BPC-157 safe to inject?
+
-
The experimental peptide BPC-157 is prohibited under the World Anti-Doping Agency (WADA) Prohibited List in the category of S0 Unapproved Substances. Furthermore, this substance is not approved for human clinical use by any global regulatory authority and it may lead to negative health effects.
How long does BPC-157 take to start working?
+
-
BPC-157 timelines depend on your injury, overall health, and protocol quality. Most patients see initial improvements within 3-4 weeks, with continued progress over months. Key takeaways: Soft tissue injuries typically respond in 2-6 weeks.
Can BPC-157 be injected intramuscularly?
+
-
Administered either subcutaneously (under the skin) or intramuscularly, BPC-157 injections are typically prescribed at a dose of 250-500 micrograms per day, depending on individual needs.
Hot Tags: bpc 157 peptide injection, China bpc 157 peptide injection manufacturers, suppliers, Botulinum Toxin Injection 100iu, Nad Capsule, Nad Peptide Injection, Nad Tablet, BPC 157 Peptide Cream, BPC 157 Peptide Capsules










